Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Milestone Pharmaceuticals Inc
MIST | US
1.59
USD-0.06
-3.64%
MIST | US
About Milestone Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
05/03/2026
Close
1.59
Open
1.64
High
1.65
Low
1.58
Milestone Pharmaceuticals Inc. a biopharmaceutical company focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil a novel and potent calcium channel blocker which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal Canada.
View LessMIST | US
Risk
45.7
Sharpe
-0.08
Luna's Score
30/100
Recommendation
Sell
Luna says (MIST | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
34.0%1 month
45.7%3 months
63.4%6 months
62.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.48
Debt to equity
1.67
Debt to assets
0.60
Ent. to EBITDA
-1.43
Ent. to rev.
81.44
PEG
-
Other Fundamentals
EBITDA
-49.19M
MarketCap
84.70M
MarketCap(USD)
84.70M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-100.00
Ret. on equity
-133.75
Short ratio
3.33
Short perc.
0.83
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.23
Range1M
0.44
Range3M
1.48
Volumes: Market Activity
Rel. volume
0.79
Price X volume
2.09M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.43 | 0.53 | Cheaper |
| Ent. to Revenue | 81.44 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.48 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 63.43 | 72.80 | Par |
| Debt to Equity | 1.67 | -1.23 | Expensive |
| Debt to Assets | 0.60 | 0.25 | Expensive |
| Market Cap | 84.70M | 3.66B | Emerging |
